OR

Healthcare · Pharmaceuticals

Ortin Global Ltd (ORTINGLOBE)

₹12.37

Mkt cap
₹11 Cr
P/E ratio
—
P/B
16.06
Div yield
0.00%
ROE
−48.40%
ROCE
−33.90%
EPS (TTM)
—
Book value
₹1
52W range
11–21
Sector
Healthcare

Price history

Previous close

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations. [1]

NSE ORTINGLOBEBSE 539287
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsBearish
52-week range
−41.92% from high
₹12
₹11+12.45% from low₹21
Current
₹12.37
Prev close
₹12.42
Day
−0.40%
Price performance
1D
+2.82%
1W
−1.24%
1M
−4.13%
3M
−19.94%
6M
−18.14%
1Y
+11.24%
YTD
−12.58%

Financials

Revenue, profit & margin
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales0.270.140.300.210.050.030.090.080.010.010.300.010.04
YoY Sales growth-65.82%-88.03%-79.87%-86.62%-81.48%-78.57%-70.00%-61.90%-80.00%-66.67%+233.33%-87.50%+300.00%
Expenses1.172.743.350.310.500.160.250.240.510.060.310.340.31
Operating Profit-0.90-2.60-3.05-0.10-0.45-0.13-0.16-0.16-0.50-0.05-0.01-0.33-0.27
OPM %-333.33%-1,857.14%-1,016.67%-47.62%-900.00%-433.33%-177.78%-200.00%-5,000.00%-500.00%-3.33%-3,300.00%-675.00%
Other Income0.000.000.000.000.000.020.000.000.000.000.000.000.00
Interest0.150.140.080.000.02-0.010.000.000.000.000.000.000.00
Depreciation0.060.060.050.000.000.000.000.000.000.000.000.000.00
Profit before tax-1.11-2.80-3.18-0.10-0.47-0.10-0.16-0.16-0.50-0.05-0.01-0.33-0.27
Tax %1.80%-0.71%30.19%0.00%0.00%10.00%0.00%6.25%0.00%0.00%0.00%0.00%0.00%
Net Profit-1.12-2.79-4.14-0.10-0.47-0.11-0.16-0.18-0.50-0.05-0.01-0.34-0.27
EPS in Rs-1.38-3.43-5.09-0.12-0.58-0.14-0.20-0.22-0.61-0.06-0.01-0.42-0.33
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −1.22% · closed higher next day 0 of last 2
 Q1FY27Q2FY27
Broadcast14 Aug '26◦11 Nov '26◦
Earnings day+0.57%−3.01%
+1 day−0.06%−7.44%
+5 days−3.23%−11.10%
+15 days−2.28%—
+30 days−6.84%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
1.24%Promoter
Promoters1.24%0.01
FIIs0.67%1.13
Public98.09%1.13
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Ortin Global₹12.93—110.00%0+46.00%0+300.00%−33.93%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings